Not a sourcing thread. Thymosin alpha-1, a fortnight, and what I can and cannot conclude from my own experience.
What the peptide class does pharmacologically does not require the subjective effect to be large to be real.
Tolerance and underdosing look identical from the inside, which is why the answer is usually a blood test and not more forums.
There is a serious question about whether the studied form matches what is sold, and nobody in a thread can answer it.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
What is the strongest human evidence anyone here has actually read, not skimmed?
My rule, after years of this: if it cannot survive being written down with the numbers attached, it is marketing.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Same here.
Same for me with thymosin alpha-1, unfortunately.